Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design.
Saved in:
| Title: | Assessment of the clinical utility of four NGS panels in myeloid malignancies. Suggestions for NGS panel choice or design. |
|---|---|
| Authors: | Aguilera-Diaz A; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain., Vazquez I; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Ariceta B; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Mañú A; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Blasco-Iturri Z; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Palomino-Echeverría S; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., Larrayoz MJ; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain., García-Sanz R; Hematology Department, University Hospital of Salamanca, IBSAL and CIBERONC, Salamanca, Spain., Prieto-Conde MI; Hematology Department, University Hospital of Salamanca, IBSAL and CIBERONC, Salamanca, Spain., Del Carmen Chillón M; Hematology Department, University Hospital of Salamanca, IBSAL and CIBERONC, Salamanca, Spain., Alfonso-Pierola A; Hematology Department, Clinica Universidad de Navarra (CUN), Pamplona, Spain., Prosper F; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematology Department, Clinica Universidad de Navarra (CUN), Pamplona, Spain., Fernandez-Mercado M; Advanced Genomics Laboratory, Hemato-Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Biomedical Engineering Department, School of Engineering, University of Navarra, San Sebastian, Spain., Calasanz MJ; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.; Hematological Diseases Laboratory, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain.; Scientific Co-Director of CIMA LAB Diagnostics, CIMA LAB Diagnostics, University of Navarra, Pamplona, Spain. |
| Source: | PloS one [PLoS One] 2020 Jan 24; Vol. 15 (1), pp. e0227986. Date of Electronic Publication: 2020 Jan 24 (Print Publication: 2020). |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
